MedTrace Logo

UCB Therapy in Acquired Brain Injury

NCT01885663 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2017-10-12

No results posted yet for this study

Summary

This open label trial is conducted to investigate the efficacy and safety of allogeneic umbilical cord blood (UCB) therapy for patients with acquired brain injury.

Conditions

  • Acquired Brain Injury

Interventions

PROCEDURE

Umbilical cord blood therapy

Intravascular umbilical cord blood therapy

Sponsors & Collaborators

  • MinYoung Kim, M.D.

    lead OTHER

Principal Investigators

  • MinYoung Kim, M.D., Ph.D. · CHA University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01885663 on ClinicalTrials.gov